106949-90-0

Basic information

• Product Name: Phenol, 4-mercapto-2,5-dimethyl-
• CAS NO: 106949-90-0
• Molecular Formula: C8H10OS
• Molecular Weight: 154.233
• Mol File: 106949-90-0.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: Phenol, 4-mercapto-2,5-dimethyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Phenol, 4-mercapto-2,5-dimethyl-(106949-90-0)
• EPA Substance Registry System: Phenol, 4-mercapto-2,5-dimethyl-(106949-90-0)

Safety Data

• Hazardous Substances Data: 106949-90-0(Hazardous Substances Data)

Upstream product

• 6186-85-2 2,5-Dimethyl-4-thiocyanato-phenol 

Downstream Products

• 1207268-96-9 ethyl 2-(2,5-dimethyl-4-(1-(3-(4-n-butyl-5-oxo-1-(4-trifluoromethyl-phenyl)-4,5-dihydrogen-1H-1,2,4-triazolyl))-benzylthio)-phenoxy)-acetate 
• 1207268-89-0 ethyl 2-(2,5-dimethyl-4-(1-(3-(4-methyl-5-oxo-1-(4-trifluoromethyl-phenyl)-4,5-dihydrogen-1H-1,2,4-triazolyl))-benzylthio)-phenoxy)-acetate 
• 85629-75-0 5-[4-(4-Carboxy-4-methyl-pentyloxy)-2,5-dimethyl-phenylsulfanyl]-2,2-dimethyl-pentanoic acid 
• 7379-48-8 2,5-(CH₃)2-4-CH₃S-C₆H₂OH 

Relevant articles and documents

COMPOUND WITH AGITATION EFFECT ON PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR , AND PREPARATION METHOD AND USE THEREOF

The present invention provides a novel compound of formula I, which has an agitation effect on the peroxisome proliferator-activated receptor subtype δ (PPARδ), to a pharmaceutical composition comprising the compound, to a process for preparation of the compound and to use of the compound in the manufacture of a medicament for treating or preventing a disease which could be treated or prevented by activating PPARδ thereof, said disease is one or more from the group comprising metabolic syndrome, obesity, dyslipidemia, pathoglycemia, insulin resistance, senile dementia and tumors. The present invention also relates to a new intermediate used in the preparation of the novel compound and a process for preparation of the intermediate.

COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS

The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of the Peroxisome Proliferator-Activated Receptor (PPAR) families.

COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS

The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of the Peroxisome Proliferator-Activated Receptor (PPAR) families.